Literature DB >> 12787281

Immunotherapy for recalcitrant warts in children using intralesional mumps or Candida antigens.

Missy M Clifton1, Sandra Marchese Johnson, Paula K Roberson, Jay Kincannon, Thomas D Horn.   

Abstract

Intralesional injection of mumps and Candida skin test antigens has been shown to be effective in the treatment of warts. Warts are generally difficult to treat in children. To determine the efficacy of intralesional skin test antigen injection for the treatment of resistant warts in children, we treated 47 pediatric patients with one or more warts with intralesional injection of mumps or Candida skin test antigen into one wart. Twenty-two patients (47%) with resistant warts experienced complete resolution of treated warts. An average of 3.78 treatments were necessary. An additional 34% of children had a greater than 25% improvement in their warts. Sixty-eight percent of subjects with more than one wart also noted at least partial resolution (greater than 25% resolution) of untreated warts at distant sites, with 34% experiencing complete resolution. We concluded that intralesional injection of skin test antigens is an effective therapy for children who have recalcitrant, nongenital, cutaneous warts.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12787281     DOI: 10.1046/j.1525-1470.2003.20318.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  26 in total

1.  Management of Difficult-to-Treat Warts: Traditional and New Approaches.

Authors:  Peter C Friedman
Journal:  Am J Clin Dermatol       Date:  2021-01-11       Impact factor: 7.403

Review 2.  An armamentarium of wart treatments.

Authors:  Michelle M Lipke
Journal:  Clin Med Res       Date:  2006-12

3.  Bleomycin-Coated Microneedles for Treatment of Warts.

Authors:  Han Sol Lee; Ha Ryeong Ryu; Joo Young Roh; Jung-Hwan Park
Journal:  Pharm Res       Date:  2016-11-17       Impact factor: 4.200

Review 4.  Cross-Reactivity, Epitope Spreading, and De Novo Immune Stimulation Are Possible Mechanisms of Cross-Protection of Nonvaccine Human Papillomavirus (HPV) Types in Recipients of HPV Therapeutic Vaccines.

Authors:  Mayumi Nakagawa; William Greenfield; Andrea Moerman-Herzog; Hannah N Coleman
Journal:  Clin Vaccine Immunol       Date:  2015-05-06

5.  Human papillomavirus type 16 viral load is decreased following a therapeutic vaccination.

Authors:  Hannah N Coleman; William W Greenfield; Shawna L Stratton; Rita Vaughn; Alexander Kieber; Andrea M Moerman-Herzog; Horace J Spencer; Wilbur C Hitt; Charles Matthew Quick; Laura F Hutchins; Samuel G Mackintosh; Ricky D Edmondson; Stephen W Erickson; Mayumi Nakagawa
Journal:  Cancer Immunol Immunother       Date:  2016-03-15       Impact factor: 6.968

Review 6.  Skin conditions of baseball, cricket, and softball players.

Authors:  Joshua A Farhadian; Brook E Tlougan; Brian B Adams; Jonathan S Leventhal; Miguel R Sanchez
Journal:  Sports Med       Date:  2013-07       Impact factor: 11.136

Review 7.  Verruca vulgaris of the tongue: a case report with a literature review.

Authors:  Ahmet Ural; Selçuk Arslan; Şafak Ersoz; Betül Değer
Journal:  Bosn J Basic Med Sci       Date:  2014-08-16       Impact factor: 3.363

8.  A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with Candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3.

Authors:  William W Greenfield; Shawna L Stratton; Rebecca S Myrick; Rita Vaughn; Lisa M Donnalley; Hannah N Coleman; Maria Mercado; Andrea M Moerman-Herzog; Horace J Spencer; Nancy R Andrews-Collins; Wilbur C Hitt; Gordon M Low; Nirvana A Manning; Samantha S McKelvey; Dora Smith; Michael V Smith; Amy M Phillips; C Matthew Quick; Susanne K Jeffus; Laura F Hutchins; Mayumi Nakagawa
Journal:  Oncoimmunology       Date:  2015-05-27       Impact factor: 8.110

9.  IL-12 secretion by Langerhans cells stimulated with Candida skin test reagent is mediated by dectin-1 in some healthy individuals.

Authors:  Mayumi Nakagawa; Hannah N Coleman; Xuelian Wang; Jaclyn Daniels; James Sikes; Uma M Nagarajan
Journal:  Cytokine       Date:  2013-12-02       Impact factor: 3.861

10.  Candida skin test reagent as a novel adjuvant for a human papillomavirus peptide-based therapeutic vaccine.

Authors:  Xuelian Wang; Hannah N Coleman; Uma Nagarajan; Horace J Spencer; Mayumi Nakagawa
Journal:  Vaccine       Date:  2013-10-14       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.